$0.211
-0.007 (-3.21%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PDSB Prediction & Forecast by Similar Chart Analysis
Alphio's PDSB stock price prediction model matches the current PDS Biotechnology Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.21 (+0.02%). The 1-week path is $0.21 (-0.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy PDS Biotechnology Corp Stock?
PDS Biotechnology Corp is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $0.2109, and the company has a negative net income of approximately $7.3 million for Q1 2026, indicating ongoing financial struggles. Additionally, the RSI is at 18.192, suggesting that the stock is heavily oversold, which may not provide a favorable entry point for long-term investors. The main risk is the company's high debt-to-equity ratio of 407.47%, which raises concerns about financial stability.
PDSB stock price ended at $0.21 on Friday, after losing -3.21%
PDS Biotechnology Corp (PDSB) last closed at $0.2109, losing -3.21%. These facts feed the 1-day and 1-week PDSB price prediction above.
Forecast Drivers
PDS Biotechnology Corp (PDSB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PDSB, ranked by similarity.
Seasonality analysis for PDSB
Historically the probability of a positive August return for PDSB is 0.00%. January offers the highest probability of a positive month at 42.62%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PDSB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.19 | $1.39 | $1.62 | +558.43% |
| Sep 2026 | $0.98 | $1.19 | $1.21 | +466.29% |
| Oct 2026 | $0.98 | $1.07 | $1.11 | +408.52% |
| Nov 2026 | $1.17 | $1.39 | $1.46 | +558.43% |
| Dec 2026 | $0.95 | $1.14 | $1.39 | +438.55% |
In 2026, PDS Biotechnology Corp (PDSB) is projected to range from $0.95 to $1.62.
PDS Biotechnology Corp 2026 monthly forecast
In Aug 2026, PDS Biotechnology Corp is projected to average $1.39, with a low of $1.19 and high of $1.62.
In Sep 2026, PDS Biotechnology Corp is projected to average $1.19, with a low of $0.98 and high of $1.21.
In Oct 2026, PDS Biotechnology Corp is projected to average $1.07, with a low of $0.98 and high of $1.11.
In Nov 2026, PDS Biotechnology Corp is projected to average $1.39, with a low of $1.17 and high of $1.46.
In Dec 2026, PDS Biotechnology Corp is projected to average $1.14, with a low of $0.95 and high of $1.39.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.